These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 489709

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vivo effects of delta 1-testololactone on peripheral aromatization.
    Judd HL, Barone RM, Laufer LR, Gambone JC, Monfort SL, Lasley BL.
    Cancer Res; 1982 Aug; 42(8 Suppl):3345s-3348s. PubMed ID: 7083208
    [Abstract] [Full Text] [Related]

  • 3. Origin of serum estradiol in postmenopausal women.
    Judd HL, Shamonki IM, Frumar AM, Lagasse LD.
    Obstet Gynecol; 1982 Jun; 59(6):680-6. PubMed ID: 7078905
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
    Geisler J, Haynes B, Anker G, Helle H, Ekse D, Dowsett M, Lønning PE.
    J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
    [Abstract] [Full Text] [Related]

  • 8. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
    Goss PE, Powles TJ, Dowsett M, Hutchison G, Brodie AM, Gazet JC, Coombes RC.
    Cancer Res; 1986 Sep; 46(9):4823-6. PubMed ID: 2942241
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962).
    Longcope C, Femino A, Johnston JO.
    Endocrinology; 1988 May; 122(5):2007-11. PubMed ID: 3359974
    [Abstract] [Full Text] [Related]

  • 10. Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women.
    Lønning PE, Dowsett M, Jacobs S, Schem B, Hardy J, Powles TJ.
    J Steroid Biochem; 1989 May; 34(1-6):551-3. PubMed ID: 2626050
    [Abstract] [Full Text] [Related]

  • 11. Androgen-estrogen production rates in postmenopausal women with breast cancer.
    Kirschner MA, Cohen FB, Ryan C.
    Cancer Res; 1978 Nov; 38(11 Pt 2):4029-35. PubMed ID: 568029
    [No Abstract] [Full Text] [Related]

  • 12. Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
    Dowsett M, Cunningham DC, Stein RC, Evans S, Dehennin L, Hedley A, Coombes RC.
    Cancer Res; 1989 Mar 01; 49(5):1306-12. PubMed ID: 2917360
    [Abstract] [Full Text] [Related]

  • 13. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
    Nagamani M, Hannigan EV, Dillard EA, Van Dinh T.
    J Clin Endocrinol Metab; 1986 Mar 01; 62(3):508-12. PubMed ID: 3944235
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of peripheral aromatization in postmenopausal women with breast cancer.
    Barone RM, Judd HL.
    Surg Forum; 1978 Mar 01; 29():172-4. PubMed ID: 401126
    [No Abstract] [Full Text] [Related]

  • 15. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Samojlik E, Santen RJ, Kirschner MA, Ertel NH.
    Cancer Res; 1982 Aug 01; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
    [Abstract] [Full Text] [Related]

  • 16. Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
    Geisler J, Haynes B, Ekse D, Dowsett M, Lønning PE.
    J Steroid Biochem Mol Biol; 2007 Apr 01; 104(1-2):27-34. PubMed ID: 17350249
    [Abstract] [Full Text] [Related]

  • 17. Enhanced conversion of androstenedione to estrogens in obese males.
    Kley HK, Deselaers T, Peerenboom H, Krüskemper HL.
    J Clin Endocrinol Metab; 1980 Nov 01; 51(5):1128-32. PubMed ID: 7419688
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.